Genprex (2DE1) Financial Statements
Genprex Financial Overview
Genprex's market cap is currently $1.64M. The company's EPS TTM is $-158.78; its P/E ratio is -0.01; Genprex has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -6.69K | $ -15.00K | $ -25.57K | $ -22.53K |
| Operating Income | $ -15.52M | $ -21.17M | $ -31.08M | $ -23.83M | $ -20.67M |
| EBITDA | $ -15.49M | $ -21.10M | $ -30.85M | $ -23.72M | $ -20.64M |
| Net Income | $ -16.23M | $ -21.11M | $ -30.86M | $ -23.74M | $ -20.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.83M | $ 1.60M | $ 6.74M | $ 20.95M | $ 38.63M |
| Total Assets | $ 10.16M | $ 4.12M | $ 10.67M | $ 25.09M | $ 42.86M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -7.83M | $ -1.60M | $ -6.74M | $ -20.95M | $ -38.63M |
| Total Liabilities | $ 2.20M | $ 2.50M | $ 3.25M | $ 2.81M | $ 1.59M |
| Stockholders' Equity | $ 7.96M | $ 1.62M | $ 7.42M | $ 22.27M | $ 41.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.31M | $ -17.15M | $ -24.81M | $ -17.78M | $ -14.37M |
| Operating Cash Flow | $ -15.31M | $ -17.15M | $ -24.74M | $ -17.78M | $ -14.28M |
| Investing Cash Flow | $ 0.00 | $ 1.17K | $ -71.21K | $ 97.73K | $ -83.80K |
| Financing Cash Flow | $ 21.54M | $ 12.01M | $ 10.59M | $ 6.43K | $ 25.68M |
Currency in USD
